Collaboration designed to uncover new drug-target interactions at genome scale The University of Texas MD Anderson Cancer Center’sTherapeutics Discovery division and Orionis Biosciences today announced the launch of Project Helios, a research collaboration designed to unlock new drug development opportunities through genome-scale mapping of drug-target […]
